Why agilon health (AGL) Shares Are Getting Obliterated Today

Core Points - Agilon Health's shares fell 6.8% after receiving a non-compliance notice from the New York Stock Exchange due to its stock price dropping below listing standards [1][2] - The notice was triggered by the stock's average closing price remaining below $1.00 for a continuous 30-day period, following a larger-than-expected loss reported in the third quarter [2] - To avoid delisting, Agilon Health plans to seek a reverse stock split, pending stockholder approval, and has a six-month period to regain compliance [2] - A Barclays analyst also lowered the price target on Agilon Health's stock, contributing to negative sentiment [2] Financial Performance - In the third quarter, Agilon Health reported revenue of $1.44 billion, a 1.1% year-over-year decline, but narrowly exceeded analyst estimates [5] - The company posted a GAAP loss of $0.27 per share, missing the consensus estimate of a $0.17 loss, indicating significant profitability issues [5] - Full-year revenue guidance was in line with expectations, but the outlook for adjusted EBITDA was well below analyst projections [5] Stock Performance - Agilon Health's shares have experienced extreme volatility, with 77 moves greater than 5% over the last year, indicating the market views recent news as significant but not fundamentally altering its perception of the business [4] - The stock is down 65.1% year-to-date and is trading at $0.67 per share, which is 88.2% below its 52-week high of $5.68 from April 2025 [6] - An investment of $1,000 in Agilon Health's shares at the IPO in April 2021 would now be worth $21.60 [6]